Wellgistics Health and Kare PharmTech Execute Joint Venture Expanding Access to 200,000+ Patient Lives

The collaboration aims to streamline the prescription journey from intake through fulfillment.

Apr. 14, 2026 at 7:05pm

Got story updates? Submit your updates here. ›

An abstract, X-ray-like image revealing the intricate, interconnected structures of digital healthcare platforms and AI-driven technologies, conceptually representing the integration of Wellgistics Health and Kare PharmTech's systems to improve patient access to therapies.The joint venture between Wellgistics Health and Kare PharmTech aims to create a comprehensive, technology-driven platform that streamlines the prescription journey and enhances access to therapies.Today in Tampa

Wellgistics Health, a leading healthcare technology and pharmaceutical distribution company, and Kare PharmTech's subsidiary Kare Rx Hub, an AI-driven digital hub for retail pharmacy, telemedicine, and specialty pharmaceutical programs, have executed a definitive joint venture agreement. The collaboration will integrate the companies' technology platforms and operational teams to accelerate patient access and improve the efficiency of pharmaceutical commercialization.

Why it matters

This joint venture reflects Wellgistics' continued focus on building an integrated, technology-enabled platform to improve coordination across the prescription journey and support patient access to therapies. By combining Kare Rx Hub's provider connectivity and digital engagement capabilities with Wellgistics' infrastructure, the collaboration is expected to enhance operational efficiency and support manufacturers and other healthcare stakeholders in navigating access pathways more effectively.

The details

The joint venture aligns clinical, operational, and commercial teams across both organizations, enabling more seamless coordination between providers, pharmacies, and patients. Through this integration, the platform enhances key capabilities including eligibility and benefits verification, prior authorization workflows, prescription routing, and direct-to-patient fulfillment. The combined ecosystem includes a growing national footprint of independent pharmacies, provider networks, and telehealth channels, with the ability to reach more than 200,000 patient lives.

  • The joint venture agreement was executed on April 14, 2026.

The players

Wellgistics Health, Inc.

A leading healthcare technology and pharmaceutical distribution company.

Kare Rx Hub, LLC

An artificial intelligence (AI)-driven digital hub supporting retail pharmacy, telemedicine, and specialty pharmaceutical programs, and a wholly owned subsidiary of Kare PharmTech, LLC.

Prashant Patel

Chief Executive Officer of Wellgistics Health.

Mital Panera

Founder and Chief Executive Officer of Kare PharmTech, LLC.

Dr. Kiran Patel

The founder of Kare PharmTech, LLC, who previously founded WellCare and America's 1st Choice Holdings.

Got photos? Submit your photos here. ›

What they’re saying

“This joint venture reflects our continued focus on building an integrated, technology-enabled platform to improve coordination across the prescription journey and support patient access to therapies. By combining KareRx's provider connectivity and digital engagement capabilities with our infrastructure, we believe this collaboration enhances operational efficiency and supports manufacturers and other healthcare stakeholders in navigating access pathways more effectively.”

— Prashant Patel, Chief Executive Officer of Wellgistics Health

“KareRx was developed to connect providers, pharmacies, and patients through technology-driven solutions. This joint venture allows us to extend those capabilities by leveraging Wellgistics' technology stack, pharma expertise, and operational infrastructure. We believe the combined platform will support improved connectivity across stakeholders and facilitate access to therapies across participating networks.”

— Mital Panera, Founder and Chief Executive Officer of KareRx

What’s next

The joint venture remains subject to customary implementation steps, and there can be no assurance regarding the timing or extent of operational integration or the realization of anticipated benefits. Additional details regarding the joint venture agreement will be provided in a Current Report on Form 8-K to be filed by Wellgistics Health with the U.S. Securities and Exchange Commission.

The takeaway

This joint venture between Wellgistics Health and Kare PharmTech represents a significant step in aligning technology platforms and operational teams to create a unified ecosystem aimed at accelerating patient access and improving the efficiency of pharmaceutical commercialization. The combined platform is expected to streamline the prescription journey and enhance key capabilities, ultimately supporting manufacturers and healthcare stakeholders in navigating access pathways more effectively.